HIGHLIGHTS
- who: Br. et al. from the Research Campaign Laboratories, University of, Nottingham, RD, UK have published the Article: 838-844 (1992) 838-8, in the Journal: (JOURNAL) of 30/01/1992
- what: A large proportion of this work has centred on the use of the anti-folate drug methotrexate (MTX) and the monoclonal antibody 791T/36, which was raised against the human osteogenic sarcoma cell line, 791T (Embleton et_al, 1981), and recognises a 72,000 molecular weight glycoprotein (gp72) on the cell surface (Price et_al, 1983). The studies described here have shown that antibodytargeting approaches . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.